Affibody AB
Voltavägen 13, Floor 5
Bromma
SE-168 69
Tel: 46-0-8-598-83800
Fax: 46-0-8-598-83801
Website: http://www.affibody.com/
Email: contact@affibody.com
36 articles about Affibody AB
-
Swedish Orphan Biovitrum Signs Licensing Agreement With Affibody For IL-1
4/22/2016
-
Affibody Enter Into An Option Agreement Regarding IL-17-Targeting Molecules In Ophthalmology
4/12/2016
-
Affibody Release: Method For Better Treatment Of Breast Cancer
1/18/2016
-
Affibody Receives Clinical Milestone From Daiichi Sankyo
12/2/2015
-
Affibody And Biotest AG Enter Into A Research License And Option Agreement Regarding The Albumod Platform
6/1/2015
-
Nordic Nanovector And Affibody Collaborate On Advanced Radio-Immunotherapies Program For Multiple Myeloma
12/1/2014
-
Nordic Nanovector And Affibody Collaborate On New Advanced Radio-Immunotherapies Program For Multiple Myeloma
11/26/2014
-
Swedish Orphan Biovitrum Enters Research Collaboration With Affibody Within the IL-1 Field
7/10/2012
-
GE Healthcare and Affibody to Collaborate on Her2 specific PET Imaging Agent for Breast and Gastric Cancer
6/7/2012
-
GE Healthcare and Affibody to Collaborate on Her2 specific PET Imaging Agent for Breast and Gastric Cancer
6/4/2012
-
Biovitrum AB Gets Access to Affibody Technology
3/24/2009
-
Affibody to Start Clinical Development of a New Approach for the Diagnosis of Cancer
9/26/2007
-
Affibody Issues New Shares of SEK 200 Million
3/30/2007
-
Affibody And GE Healthcare Enter A Research Agreement
6/19/2006
-
Clinical Data On Molecular Imaging Of Breast Cancer Metastases Using Anti-HER2 Affibody® Molecules
6/7/2006
-
Affibody Appoints Dr. Ulf Boberg As Chief Executive Officer
6/1/2006